BANK VONTOBEL/PUT/MEDTRONIC/65/0.1/20.09.24 Share Price

Warrant

DE000VD18JH3

Market Closed - Bid/Ask 11:24:48 05/07/2024 pm IST After market 12:30:39 am
0.009 EUR -30.77% Intraday chart for BANK VONTOBEL/PUT/MEDTRONIC/65/0.1/20.09.24 0.016 +77.78%
Current month+12.50%
1 month-10.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 0.009 -30.77%
04/24/04 0.013 +8.33%
03/24/03 0.012 -7.69%
02/24/02 0.013 0.00%
01/24/01 0.013 +62.50%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 11:24 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VD18JH
ISINDE000VD18JH3
Date issued 14/03/2024
Strike 65 $
Maturity 20/09/2024 (77 Days)
Parity 10 : 1
Emission price 0.04
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.075
Lowest since issue 0.006
Delta-0.05x
Omega 20.29
Premium16.5x
Gearing448.12x
Moneyness 0.8372
Difference Strike -12.72 $
Difference Strike %-19.56%
Spread 0.012
Spread %54.55%
Theoretical value 0.0155
Implied Volatility 25.05 %
Total Loss Probability 94.43 %
Intrinsic value 0.000000
Present value 0.0155
Break even 64.83 €
Theta-0x
Vega0x
Rho-0x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.17 USD
Average target price
94.02 USD
Spread / Average Target
+21.84%
Consensus